Evaluation of Low Level Laser Therapy and Lidocaine Versus Chlorhexidine for the Management of Traumatic Oral Ulcers in Children

NCT ID: NCT07138586

Last Updated: 2025-09-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-01-24

Study Completion Date

2025-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

the goal of the study was to evaluate the pain reduction and healing efficiency of traumatic oral ulcers in children using low-level laser therapy with diode laser 980 nm, lidocaine oral gel and chlorhexidine mouthwash

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

thirty children were randomly allocated to three groups of ten individuals each: Group one: therapy, Group two: using Lidocaine gel 4 times daily and Group three using chlorhexidine mouthwash 4 times daily .

Assessment was done by evaluating pain by Visual Analogue scale; VAS (primary outcome) and assessment of ulcer size by periodontal probe (Secondary outcome) and Parental acceptance of the therapy (tertiary outcome) immediately after treatment, at day two, five, seven, then at two weeks

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Traumatic Ulcer of Oral Mucosa

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

the study design was a single blinded randomized clinical study
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors
the outcomes assessor was un aware of the type of treatment given to the patient

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

low level laser therapy group

patients received low level laser therapy using diode laser 980 nm

Group Type EXPERIMENTAL

low level laser therapy group

Intervention Type RADIATION

patients received low level laser therapy using diode laser 980 nm with a low power

Lidocaine gel group

patients were instructed to use Lidocaine gel (Oracure gel) 4 times daily.

Group Type EXPERIMENTAL

Lidocaine gel group

Intervention Type DRUG

patients was instructed to use Lidocaine gel (Oracure gel) 4 times daily.

Chlorhexidine mouthwash group (positive control group).

patients were instructed to use Chlorhexidine mouthwash (Orovex) 4 times daily (control group).

Group Type EXPERIMENTAL

Chlorhexidine mouthwash group (positive control group).

Intervention Type DRUG

patients was instructed to use Chlorhexidine mouthwash (Orovex) 4 times daily (control group).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

low level laser therapy group

patients received low level laser therapy using diode laser 980 nm with a low power

Intervention Type RADIATION

Lidocaine gel group

patients was instructed to use Lidocaine gel (Oracure gel) 4 times daily.

Intervention Type DRUG

Chlorhexidine mouthwash group (positive control group).

patients was instructed to use Chlorhexidine mouthwash (Orovex) 4 times daily (control group).

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

low level laser therapy- biostimulation Oracure gel Orovex mouthwash

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Children from 4-12 years without any apparent medical problem
* Children with history of receiving a dental procedure in the same or the previous day of the onset of ulcer.
* Children having restorations or teeth with sharp edges.
* Children with orthodontic or any other oral appliance.
* No previous treatment with any modality for the ulcer.
* Willingness to participate in the proposed clinical study.

Exclusion Criteria

* Patients who had psychological or mental diseases.
* Patient under anticoagulants, anti-inflammatory or immunosuppressant medications.
* Children with systemic (endocrine-metabolic) disease; rheumatologic disease; hormone disorder; immunodeficiency; use of corticoid-based therapy.
* Uncooperative children or parents.
* Patients who did not participate twice weekly in the evaluations were excluded
Minimum Eligible Age

4 Years

Maximum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Research Centre, Egypt

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Maryam m El Mansy, researcher

Role: PRINCIPAL_INVESTIGATOR

The National Research Centre, Egypt

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

the National research Centre

Dokki, Giza Governorate, Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

0342

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Oraverse Versus Laser
NCT05473858 UNKNOWN PHASE3